Loading organizations...
§ Private Profile · Shenzhen, Guangdong, China
Jingtong Life Insurance is a company developing innovative regenerative anti-aging drugs.
Jingtong Life Insurance operates as a private startup, established in 2022 with a strategic focus on advancing regenerative medicine. The company's core mission revolves around the development of innovative drugs designed to address anti-aging processes through regenerative approaches. This specialization positions Jingtong Life Insurance within the evolving landscape of biotechnology and life sciences, aiming to contribute to solutions for age-related conditions.
Key people at Jingtong Life Insurance.
Jingtong Life Insurance has received funding from both CAS Star and Cybernaut Venture Capital.
Jingtong Life Insurance is focused on developing innovative regenerative anti-aging drugs.
Jingtong Life Insurance has received funding from both CAS Star and Cybernaut Venture Capital.
Jingtong Life Insurance is focused on developing innovative regenerative anti-aging drugs.
Key people at Jingtong Life Insurance.
Jingtong Life Insurance most recently raised Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 4, 2026 | Seed | CAS Star, Cybernaut Venture Capital | — | Announced |
Operating from its headquarters in Shenzhen, Guangdong, China, Jingtong Life Insurance leverages its geographical location within a prominent innovation hub. The company's legal designation is Shenzhen Jingtong Life Science Co., Ltd., reflecting its scientific and corporate identity.
Since its inception, Jingtong Life Insurance has attracted investment from venture capital firms. Notably, CAS Star and Cybernaut Venture Capital have provided funding, indicating external confidence in the company's research direction and potential within the regenerative anti-aging drug market. These investments support the company's ongoing development activities and operational growth.
As a startup in the life sciences sector, Jingtong Life Insurance is engaged in the complex and long-term process of drug development. Its work in regenerative anti-aging drugs targets a significant and growing area of medical research, aiming to bring new therapeutic options to market.
